JP2008531559A5 - - Google Patents

Download PDF

Info

Publication number
JP2008531559A5
JP2008531559A5 JP2007557016A JP2007557016A JP2008531559A5 JP 2008531559 A5 JP2008531559 A5 JP 2008531559A5 JP 2007557016 A JP2007557016 A JP 2007557016A JP 2007557016 A JP2007557016 A JP 2007557016A JP 2008531559 A5 JP2008531559 A5 JP 2008531559A5
Authority
JP
Japan
Prior art keywords
hydrogen
cycloalkyl
ring
alkyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007557016A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008531559A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/044713 external-priority patent/WO2006093548A1/en
Publication of JP2008531559A publication Critical patent/JP2008531559A/ja
Publication of JP2008531559A5 publication Critical patent/JP2008531559A5/ja
Withdrawn legal-status Critical Current

Links

JP2007557016A 2005-02-25 2005-12-09 スピロ−複素環式クロマン、チオクロマン及びジヒドロキノリン Withdrawn JP2008531559A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65671105P 2005-02-25 2005-02-25
US65674805P 2005-02-25 2005-02-25
PCT/US2005/044713 WO2006093548A1 (en) 2005-02-25 2005-12-09 Spiro-heterocyclic chromans, thiochromans and dihydroquinolines

Publications (2)

Publication Number Publication Date
JP2008531559A JP2008531559A (ja) 2008-08-14
JP2008531559A5 true JP2008531559A5 (enExample) 2009-01-15

Family

ID=36941473

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007557016A Withdrawn JP2008531559A (ja) 2005-02-25 2005-12-09 スピロ−複素環式クロマン、チオクロマン及びジヒドロキノリン

Country Status (8)

Country Link
US (1) US20080207588A1 (enExample)
EP (1) EP1856079A4 (enExample)
JP (1) JP2008531559A (enExample)
AU (1) AU2005328328A1 (enExample)
BR (1) BRPI0520097A2 (enExample)
CA (1) CA2600004A1 (enExample)
MX (1) MX2007010328A (enExample)
WO (1) WO2006093548A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006065686A2 (en) 2004-12-13 2006-06-22 Galileo Pharmaceuticals, Inc. Spiro derivatives as lipoxygenase inhibitors
CA2924141C (en) 2013-08-22 2022-06-07 The General Hospital Corporation 5-amino 4-cyano substituted oxazole and thiazole derivatives as inhibitors of human 12/15-lipoxygenase
RU2720237C2 (ru) 2013-11-18 2020-04-28 Форма Терапеутикс, Инк. Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
DK3071203T3 (da) 2013-11-18 2021-03-15 Forma Therapeutics Inc Tetrahydroquinolinsammensætninger som bet-bromdomæne-inhibitorer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261835A (en) 1984-08-20 1989-09-26 Masaaki Toda (fused) benz(thio)amides
GB8626344D0 (en) 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
US5059609A (en) 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
US4950684A (en) 1988-05-20 1990-08-21 G. D. Searle & Co. 2,2-di-substituted benzopyran leukotriene-D4 antagonists
US5015661A (en) 1988-08-09 1991-05-14 Hoffmann-La Roche Inc. Chromanes and their pharmaceutical compositions and methods
US5250547A (en) 1991-08-29 1993-10-05 Syntex (U.S.A.) Inc. Benzopyran derivatives
CA2124086A1 (en) 1991-11-22 1993-05-27 Ronald H. Lane Tocotrienols and tocotrienol-like compounds and methods for their use
FR2695387B1 (fr) 1992-09-09 1994-10-21 Adir Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5686389A (en) * 1994-04-13 1997-11-11 City Of Hope Growth inhibition of Erwinia amylovora
JP3012339B2 (ja) 1994-10-13 2000-02-21 ファイザー・インコーポレーテッド ベンゾピランおよびベンゾ縮合化合物、それらの製造、並びにロイコトリエンb▲下4▼(ltb▲下4▼)アンタゴニストとしてのそれらの用途
WO1996011920A1 (en) 1994-10-13 1996-04-25 Pfizer Inc. Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists
US5925673A (en) 1994-12-23 1999-07-20 Alcon Laboratories, Inc. Benzofurans and benzopyrans as cytoprotective agents
TW472051B (en) * 1997-05-23 2002-01-11 Chugai Pharmaceutical Co Ltd 2,3-dihydrobenzofuran derivatives
WO2006065686A2 (en) * 2004-12-13 2006-06-22 Galileo Pharmaceuticals, Inc. Spiro derivatives as lipoxygenase inhibitors
AU2005328327A1 (en) * 2005-02-25 2006-09-08 Galileo Pharmaceuticals, Inc. Novel lipoxygenase inhibitors

Similar Documents

Publication Publication Date Title
JP2021508686A5 (enExample)
CN103570725B (zh) 哌嗪并三唑类化合物及其制备方法和用途
JP2012515724A5 (enExample)
JP2022166179A (ja) アミノピリジン誘導体化合物の塩、その結晶形態、及びその調製プロセス
JP6627835B2 (ja) Kcnq2〜5チャネル活性化剤
JP7683930B2 (ja) セミカルバジド感受性アミンオキシダーゼ阻害剤の調製及びその応用
JP2010524930A5 (enExample)
WO2009062402A1 (en) Quinazolinone derivatives, the preparation methods and uses thereof
JP2009530302A5 (enExample)
JP6592512B2 (ja) 三環式アトロプ異性体の化合物
JP2012502980A5 (enExample)
JP2010523562A5 (enExample)
AU2004278158A1 (en) Imidazopyridine substituted tropane derivatives with CCR5 receptor antagonist activity for the treatment of HIV and inflammation
JP2018515623A5 (enExample)
JP2014524476A5 (enExample)
JP2011517443A5 (enExample)
JP2007509043A5 (enExample)
JP2009515984A5 (enExample)
JP2008531559A5 (enExample)
JP2006509781A (ja) インドール−3−カルボキサミドの誘導体、それらの製造方法および治療用途
JP5460614B2 (ja) アゼチジン誘導体、それらの調製、およびそれらの治療における適用
JP7661969B2 (ja) 1,4,5,6-テトラヒドロピリミジン-2-アミン誘導体
JP2009519988A5 (enExample)
KR20110010725A (ko) 무스카린성 수용체 길항제 및 β2­아드레날린수용체 효능제를 포함하는 제약 생성물
WO2017183723A1 (ja) Kcnq2~5チャネル活性化剤